University Reproductive Associates Becomes First IVF Center in NJ to Offer LifeAire Purification

The doctors at University Reproductive Associates (URA) of New Jersey

The technology has been shown to increase in vitro fertilization (IVF) success rates by up to 20%

HASBROUCK HEIGHTS, NJ, UNITED STATES, March 15, 2018 /EINPresswire.com/ — A new technology will be a game-changer in fertility treatment success in New Jersey. University Reproductive Associates (URA) is New Jersey’s first in vitro fertilization (IVF) center to introduce LifeAire, the cutting-edge technology that increases the likelihood of successful implantation and ongoing pregnancy rates by 15–20%. This powerful, in-duct air purification system remediates 99.999% of pathogens and volatile organic compounds (VOCs) in the air before it reaches the lab at URA, and fortifies URA's already highly heralded, state-of-the-art diagnostic testing procedures and treatment options to help fulfill patients' dreams of becoming parents through IVF.

URA is the first and only IVF center in the state to adopt this remarkable new technology into its already state-of-the-art IVF laboratory. The physicians, lab specialists, nurses and staff at URA deliver care 365 days each year to increase patients' pregnancy success rates; the LifeAire purification system should produce dramatic and sustained improvement in IVF success rates. With LifeAire technology, combined with an approach of complete, patient-centered dedication, URA strives to constantly improve success for their patients suffering from infertility and reproductive disorders.

URA's Laboratory Director of Embryology, Dr. Jindal, discusses the impact of LifeAire: "I have personally seen the LifeAire system produce amazingly improved outcomes at another IVF lab in Florida where I act as a consultant. More embryos develop into successful blastocysts, which is the stage embryos need to reach to be able to implant successfully, which leads to more available good, quality embryos for transfer or for freezing for future use. These laboratory improvements lead directly to dramatically better pregnancy rates and more successful IVF cycles."

URA physicians are recognized as leading authorities in the field by being chosen as reviewers and editors for prestigious medical journals, including Fertility and Sterility, Human Reproduction, Obstetrics and Gynecology, the American Journal of Obstetrics and Gynecology, the Journal of Clinical Endocrinology and Metabolism and Topics in Obstetrics and Gynecology. They are also educators for two separate OB/GYN residency programs, and they direct the only REI Fellowship training program based in the state of New Jersey.

Leonard Schwartz
University Reproductive Associates
201-288-7543
email us here


Source: EIN Presswire

House Of Medicine Opens The Door To Addiction Prevention And Treatment

1,200 Physicians Formally Certified as Addiction Medicine Specialists; Pathway Open to Specialty Training for Physicians in Accredited Programs

BETHESDA, MARYLAND, UNITED STATES, March 15, 2018 /EINPresswire.com/ — Two landmark developments in medicine pave the way for quality medical care to address America's largest and most costly preventable health problem – unhealthy substance use and addiction involving all addictive substances. These changes are designed to increase the number of addiction medicine physician specialists who can provide direct patient care and consultation, teach other providers and thereby drive knowledge across health care, and help policymakers and the public understand and effectively respond to our current health crisis.

"These developments will change the landscape in substance use prevention and early intervention and in addiction treatment and management. Many more trained physicians will be available to address the opioid crisis and other addictions. They will also be able to help prevent and intervene early with unhealthy substance use in all its forms," said Lon R. Hays, MD, President of The Addiction Medicine Foundation and Director of the University of Kentucky Addiction Medicine Fellowship Program. "For the first time, when aspiring physicians consider a career path they will now have as an available choice an addiction medicine specialty that meets the highest standards of medicine."

The first development is the formal certification of 1,200 addiction medicine physicians by the American Board of Medical Specialties (ABMS) – the gold standard in physician certification. The administrative sponsoring board for the new field is the American Board of Preventive Medicine (ABPM). In 2015, addiction medicine was recognized by ABMS as a subspecialty available to physicians from all medical fields who were already certified by an ABMS member board. The first certification exam was administered in the fall of 2017 and this first cohort of physicians has just been certified; future exams will be offered annually.

The second key development is that the medical body that accredits physician specialty training programs in the U.S. — the Accreditation Council for Graduate Medical Education (ACGME) — has opened the pathway for accrediting subspecialty training programs in addiction medicine. These are one-year, full-time training programs that physicians may apply to after they have completed a residency in a primary specialty such as internal medicine, family medicine or pediatrics. In these fellowship programs, physicians are trained in a wide range of clinical venues in the care of people engaged in unhealthy substance use or who meet medical criteria for a substance use disorder — from hospital wards, to outpatient programs and community primary care clinics and practices. Upon completion, physicians will be able to work as expert clinicians in these environments as well as engage in teaching, research, advocacy and administrative positions that require in-depth expertise.

Medical schools and teaching hospitals can now seek formal accreditation for addiction medicine training in accordance with ACGME approved program requirements. The Addiction Medicine Foundation developed a set of core competencies and program requirements for its fellowship programs with anticipated ACGME program accreditation in mind. The new ACGME program requirements closely mirror those now in place. ACGME accreditation will also enable fellowship programs to apply for funding from the Centers for Medicare & Medicaid Services and the Veterans Health Administration.

To date, 55 addiction medicine fellowship (training) programs (52 in U.S.; three in Canada) have been established at leading North American medical schools and hospitals, with the assistance of The Addiction Medicine Foundation. It is expected that the 52 fellowship programs based in the U.S. – and many more – will apply to become accredited by the ACGME. The Addiction Medicine Foundation projects that at least 125 addiction medicine fellowship programs are needed and will receive accreditation by 2025.

"We have been waiting for this moment when addiction medicine specialists can join the mainstream of American medicine and expand the critically needed addiction prevention and treatment workforce," said Anna Lembke, MD, who serves as President of the independent Addiction Medicine Fellowship Directors Association, and directs the Stanford University Addiction Medicine Fellowship.

There is a profound need for knowledge in addressing this disease and its prevention and treatment across primary care and in many areas of specialty care practice. Risky substance use and addiction constitute America's largest and most costly preventable health problem. Approximately 40 million people in the U.S. have the disease of addiction, yet only about one in 10 receive any form of treatment. These landmark changes will help ensure that trained physicians are available to address the full range of medical conditions related to the use of addictive substances, including psychiatric disorders.

To learn more about The Addiction Medicine Foundation, or to support their work in expanding physician training, go to www.AddictionMedicineFoundation.org, or call 301-656-3880. AGCME program requirements and applications can be found at www.ACGME.org (they are also available on the TAMF website at http://www.addictionmedicinefoundation.org/acgme-application-now-available-for-addiction-medicine-fellowship-accreditation/). Physician addiction medicine certification requirements are described on the www.TheABPM.org site.

Dennis Tartaglia
The Addiction Medicine Foundation
732-545-1848
email us here


Source: EIN Presswire

Antimicrobial resistance research, funding and incentives – get updates next week in London at SMi event

Superbugs & Superdrugs Conference

Superbugs & Superdrugs Conference

LONODON, NON UNITED STATES OR CANADA, UNITED KINGDOM, March 15, 2018 /EINPresswire.com/ — SMi reports: Antimicrobial resistance was predicted by Alexander Fleming in his Nobel lecture (1945). Since that warning, measures have been taken in acknowledgement of the threat of AMR, but tackling this issue is still an ongoing battle. On the global scale WHO has been the most instrumental body to take action. SMi Group is proud to be part of the fight with the Superbugs & Superdrugs Conference. Now in its 20th year, the event has firmly become established as the industry's premier platform for updates on antimicrobial resistance research, funding and incentives.

Conference is taking place in London on 19 – 20 March. To join and be a part of the global force head on to Superbugs & Superdrugs website to book your attendance http://www.superbugssuperdrugs.com/ein

PROGRAMME HIGHLIGHTS:

Analyse the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR
• Jean-Pierre Paccaud, Director of Business Development at GARDP, Drugs for Neglected Diseases initiative (DNDi) – Day 1, 9:15
• Steve Holden, Medical Adviser, MSD – Day 1, 10:35

Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress
• Conrad Lichtenstein, CSO, Nemesis bioscience – Day 1, 12:15
• David Brown, Managing Director and Founder, Alchemy Biomedical Consulting – Day 1, 12:55
• Learn about regulatory pathways for the registration of new antimicrobial agents:
• Mair Powell, Senior clinical assessor, MHRA – Day 2, 9:50

Evaluate the latest incentives and funding solutions to spur drug discovery:
• Mark Albrecht, Health Scientist, HHS/ASPR/BARDA – Day 1, 9:55
• Adrian Towse, Director, Office of Health Economics – Day 2, 10:30

Explore the latest novel alternatives to antibiotics currently in development:
• Cara Cassino, Chief Medical Officer, ContraFect – Day 2, 15:10
• Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS Inc – Day 2, 16:20
• Ian Henderson , Professor of Microbial Biology, University Of Birmingham – Day 2, 17:00

View the programme, speaker line-up, and book to attend at http://www.superbugssuperdrugs.com/ein

Superbugs & Superdrugs Team look forward to welcoming you next week to what is shaping up to be another successful show!

Contact:
+44 (0)20 7827 6000
events@smi-online.co.uk

STAY CONNECTED
LinkedIn – search 'SMi Pharma'
Twitter – @SMIpharm #smibugs

——————————————————————————————-
Superbugs & Superdrugs Conference | 19 – 20 March 2018 | London, UK
http://www.superbugssuperdrugs.com/ein
——————————————————————————————-

Luda Durneva
SMi Group
email us here
+44 (0)20 7827 6000


Source: EIN Presswire

Invivo Robotics – New Cardio Services Surgery Expansion

Invivo Robotics Sealer takes seriously its job to provide high quality technologies that improve lives by providing knowledge to patients and tools to doctors

People in medical technology, especially cardiovascular, have really felt a responsibility to improve the technology, build upon previous innovations to come up with new innovations”

— Chris Leung

SHANGHAI, CHINA, March 15, 2018 /EINPresswire.com/ — Invivo Robotics, one of the pioneers in the rapidly emerging field of robotic-assisted minimally invasive surgery, is pleased to announce its cardio services surgery portfolio.
The sooner we can help get you start feeling better, the sooner you can get back to living your fullest, healthiest life. Supporting the healthy beat of your heart it is essential to the work we do at Invivo Robotics.
"People in medical technology, especially cardiovascular, have really felt a responsibility to improve the technology, build upon previous innovations to come up with new innovations, as our primary purpose," said Chris Leung, Head of Global Product Development. "And that would in turn advance health outcomes, making the patients a little better off."
Here's just a sample of our expanding portfolio to care for your heart:
• The Cardio Invivo Robotics System is an invention that addresses heart failure. Some researchers have calculated the annual worldwide economic burden of heart failure to be over $100 billion, a cost primarily driven by hospital readmissions. The Cardio Invivo Robotics System is heart failure monitoring device that has been proven to significantly reduce heart failure hospital admissions when used by physicians to manage heart failure in certain classes of patients.
• The new Invivo Robotics Cardiac Mapping System enables faster, more accurate heart mapping during catheter ablation to enable more efficient treatment of a wide range of arrhythmias — including atrial fibrillation and other complex arrhythmias (when your heart is beating too quickly, slowly or out of rhythm).
• Invivo Robotics Mitral™, our transcatheter mitral valve therapy, is a safer option for surgical high-risk patients with severe degenerative mitral regurgitation (DMR).
"With Invivo Robotics’ role as a pioneer in cardiovascular technology, we need to be driving innovations that really improve patients’ lives and reduce the overall burden of cardiovascular disease. Not only are we just pushing technology forward, we’re responsible for creating much better outcomes that in turn reduce the overall cost of health care and help solve this global health care economic challenge." said Lee Rong, Head of Cardiology Robotics.

About Invivo Robotics

Invivo Robotics is one of the pioneers in the rapidly emerging field of robotic-assisted minimally invasive surgery. Invivo Robotics serves globally providing technology innovation across cardiac, thoracic, urology, gynecologic, colorectal, pediatric and general surgical disciplines. The Company's surgical systems enables surgeons to operate minimally invasively. At Invivo Robotics, delivering our technology is just the beginning. The company is also committed to delivering the best customer experience. To ensure the customers gain the most utility from their Invivo Robotics systems, the firm offers a comprehensive training and education program and first-rate customer support. Invivo Robotics has strong financial backing of leading global investors

Kang Yong
Invivo Robotics
1852130-6369
email us here


Source: EIN Presswire

Global Endotracheal Tubes Market 2018 Industry Key Players, Share, Trend, Segmentation and Forecast to 2023

PUNE, INDIA, March 15, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Endotracheal Tubes Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Endotracheal Tubes Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Endotracheal Tubes Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Endotracheal Tube: A flexible plastic tube that is put in the mouth or nasal, and then down into the trachea (airway).
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Global Endotracheal Tubes market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Medtronic
Teleflex Medical
ConvaTec
Bard Medical
Smiths Medical
Fuji System
Sewoon Medical
Parker Medical
Neurovision Medical
Hollister
Well Lead
TuoRen
Sujia
Shanghai Yixin
Purecath Medical

Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Regular
Reinforced
Others

By End-User / Application
Emergency Treatment
Therapy

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2696316-2015-2023-world-endotracheal-tubes-market-research-report-by-product

Table of Contents – Key Manufacturers

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

…..

12 Key Manufacturers
12.1 Medtronic
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Teleflex Medical
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 ConvaTec
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Bard Medical
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Smiths Medical
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Fuji System
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Sewoon Medical
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Parker Medical
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Neurovision Medical
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Hollister
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Well Lead
12.12 TuoRen
12.13 Sujia
12.14 Shanghai Yixin
12.15 Purecath Medical

At any Query @ https://www.wiseguyreports.com/enquiry/2696316-2015-2023-world-endotracheal-tubes-market-research-report-by-product

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Circulating Tumor Cells Market 2018 Industry Key Players, Share, Trend, Segmentation and Forecast to 2023

PUNE, INDIA, March 15, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Circulating Tumor Cells Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Circulating Tumor Cells Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Circulating Tumor Cells Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report mainly covers Circulating Tumor Cells products, by types (CTC enrichment, CTC detection and CTC analysis), by applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others).
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Global Circulating Tumor Cells market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Janssen
Qiagen(Adnagen)
Acousys Biodevices, Inc
ApoCell
Advanced Cell Diagnostics
Fluxion Biosciences
Biocept
Fluidigm
Epic Sciences
Clearbridge Biomedics
Cynvenio
CytoTrack
ScreenCell
Creatv Microtech
Aviva Biosciences
Greiner Bio-one GmbH
Sysmex Corporation
Ikonisys

Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
CTC enrichment
CTC detection
CTC analysis

By End-User / Application
Prostate Cancer
Breast Cancer
Colorectal Cancer
Others

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2696308-2015-2023-world-circulating-tumor-cells-market-research-report-by

Table of Contents – Key Manufacturers

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

…..

12 Key Manufacturers
12.1 Janssen
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Qiagen(Adnagen)
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Acousys Biodevices, Inc
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 ApoCell
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Advanced Cell Diagnostics
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Fluxion Biosciences
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Biocept
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Fluidigm
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Epic Sciences
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Clearbridge Biomedics
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Cynvenio
12.12 CytoTrack
12.13 ScreenCell
12.14 Creatv Microtech
12.15 Aviva Biosciences
12.16 Greiner Bio-one GmbH
12.17 Sysmex Corporation
12.18 Ikonisys

At any Query @ https://www.wiseguyreports.com/enquiry/2696308-2015-2023-world-circulating-tumor-cells-market-research-report-by

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Net Neutrality Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2022

Net Neutrality Market 2018 Global Industry Analysis, Opportunities and Forecast To 2022

PUNE , INDIA, March 15, 2018 /EINPresswire.com/ — Summary
America is set to change the balance of power between Internet companies like Netflix and Internet service providers (ISPs) like AT&T. On 14 December 2017, the FCC will vote on whether to eliminate net neutrality, the regulatory principle that ISPs should treat all Internet traffic equally. Supporters of net neutrality argue that an “open Internet” is essential in order to encourage innovation and free speech. Opponents of net neutrality argue that it discourages ISPs from investing in the high-speed broadband networks that the West badly needs if it is to stay ahead in the global “data revolution”.

The evidence points clearly to net neutrality rules being scrapped on 14 December 2017, because –
– President Trump and the Republican Party are both against regulatory over-reach;
– FCC Chairman, Ajit Pai, a former Verizon lawyer, is vehemently against net neutrality; and
– The US is falling down the world league table of broadband speeds, so it needs to incentivise its ISPs to invest in high speed broadband infrastructure by allowing them to charge all economic parties that benefit from using their pipes at commercial rates.

In this report we look into industry overview, trends, value chain of net neutrality, also identifying winners and losers.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3054242-net-neutrality-global-thematic-research

Companies mentioned
Advanced Info Service
Alibaba
Alphabet
America Movil
Apple
AT&T
Axiata
BCE
Belgacom
Bezeq Israeli Telecom
Bharti Airtel
BT
C&W Communications
CenturyLink
China Mobile
China Telecom
China Unicom
Chunghwa Telecom
Cisco
Colt
Consolidated Comms
Deutsche Telekom
Digi
Earthlink
Elisa
Emirates Integrated Telecom
Emirates Telecom Corp
Ericsson
Etihad Etisalat
Facebook

Scope
– This report is part of our ecosystem of thematic investment research reports, supported by our “thematic engine”.
– About our Thematic Research Ecosystem
– Research has developed a unique thematic methodology for valuing technology, media and telecom companies based on their relative strength in the big investment themes that are impacting their industry. Whilst most investment research is underpinned by backwards looking company valuation models, thematic methodology identifies which companies are best placed to succeed in a future filled with multiple disruptive threats. To do this, tracks the performance of the top 600 technology, media and telecom stocks against the 50 most important themes driving their earnings, generating 30,000 thematic scores. The algorithms in “thematic engine” help to clearly identify the winners and losers within the TMT sector. Our 600 TMT stocks are categorised into 18 sectors. Each sector scorecard has a thematic screen, a risk screen and a valuation screen. Our thematic research ecosystem has a three-tiered reporting structure: single theme, multi-theme and sector scorecard. This report is a Single Theme report, offering in-depth research into a specific theme. It identifies winners and losers based on technology leadership, market position and other factors.

Reasons to buy
– Our thematic investment research product, supported by our thematic engine, is aimed at senior (C-Suite) executives in the corporate world as well as institutional investors.
– Corporations: Helps CEOs in all industries understand the disruptive threats to their competitive landscape
– Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TMT.
– Our unique differentiator, compared to all our rival thematic research houses, is that our thematic engine has a proven track record of predicting winners and losers.

Table of Contents
PLAYERS
TRENDS
VALUE CHAIN
INDUSTRY ANALYSIS
The backdrop to the net neutrality story
Net neutrality was set up for good reasons
Regulatory policies always have unintended side effects
Both sides of the net neutrality debate have strong arguments
It now looks like net neutrality may fall in the US under President Trump
Implications if net neutrality falls
US telecom operators and cable operators may benefit
Large US Internet companies who use substantial bandwidth may lose
Global telecom equipment makers could benefit
European and Asian telecom operators may see some benefit in the medium term
If implemented sensibly, a world without net neutrality may not be so bad
TELECOM AND CABLE OPERATORS – SECTOR SCORECARD
Thematic screen
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3054242-net-neutrality-global-thematic-research

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

A New Way to Conceive a Boy or Girl: Gender Selection is done by Woman.

Mother & Child

This is how to get your dream baby.

Women have alternating boy-girl specific menstrual cycles. To get a boy, try in boy cycle. To get a girl, try in girl cycle. Please don't just keep trying.

If one has two babies of same gender, the chances of third baby to be of same gender are actually higher. The ONLY ONE system that can break that gridlock is PreGender Preconception test.”

— Kuldeep Verma

LIVONIA, MICHIGAN, UNITED STATES, March 15, 2018 /EINPresswire.com/ — A New Way to Conceive a Boy or Girl: Gender Selection is done by Woman.

Congratulations couples! Now you have full control on conceiving a boy or girl whenever you want. Don’t just keep trying.
Every couple dreams of having small and balanced 1-boy 1-girl family. When they get two babies of same gender, they start looking for ways to balance their families. According to us, if couples use our services from very beginning, a happy and balanced families can be effectively created resulting in communities with reduced spousal / domestic abuse.
Since there was no logical method available till now, numerous companies cashed on the desperation of women by selling baseless and failed ideas like Dr. Shettles hypothesis on lighter / heavier sperms affecting gender selection, boy or girl conceiving nutraceutical kits, gender diets, douches, charts and calendars etc. None of these have any basis.
The good news: Now there’s a way. In 2006, we discovered that women have alternating boy-girl specific menstrual cycles. Therefore, to get a boy, one must conceive in a boy cycle and to get a girl, do in girl cycle. This alternating gender specificity is due to release of alternating ratio of male to female hormones in uterus. Women have around 200 active eggs for conceiving boys and the same number for conceiving girls. So the effective gender planning involves management of conception in appropriate cycles. That is what PreGender Preconception test does.
Since gender selection is genetically controlled, eating or drinking anything for a short period of time is not going to work. If anyone promises you to balance your family without testing anything from you, he / she is lying.
The hormonal environments in the uterus can be determined by testing two mid-cycle urine samples collected for two consecutive months in separate bottles and shipping to our laboratory. After testing them, we keep on guiding by sending conception plans via email as to in which cycle to try and in which to avoid at no additional cost. We can also find the gender of baby as soon as one gets a positive pregnancy test. Ours is the earliest gender diagnostic test in the world.
All of this can be better understood through following graph:

We offer two types of urine tests: 1) PreGender Preconception Test, to help conceive a baby of specific gender and 2) FirstGender Post-conception Test, to evaluate the gender of the baby from day-1. Both are natural, safe, simple urine-based tests. Urine samples are collected by customers at home and mailed through any courier (UPS, FEDEX or DHL) to the lab in Livonia, Michigan, USA. It is legal to ship urine samples across international borders under classification, "Exempt Human Specimen" and the older the sample at RT, the better for these tests. No preservative is needed.
The success rate of PreGender Preconception Test is 92%. That means if 100 couples conceive in, say a boy phase, 92 will get boys and 8 can get girls. This high success rate leads us to believe that the uterus may be selecting X & Y sperms for conception depending upon the type of cycle she is in. In other words, uterus selects the gender of baby. We have nearly 300 success stories. This unique technology is protected by four patents.
For proof, customers are requested to see our results at Live Charts at www.urobiologics.com.
How to get your dream baby? Name your baby first. Participate in our Live Charts at our website where we display all the results in advance to show how couples are getting their desired babies. Get two mid-cycle urine samples tested from us to know from where to start. Thereafter, we email you conception plans in every appropriate cycle. If you conceive, collect sample for our FirstGender test and ship. Let us show one example:
Customer’s private email address (so that others can contact, not shown) Trying to conceive a girl Proposed name of baby: Rose First PreGender sample 5/22/15 showed a boy phase Second PreGender sample 6/23/15 showed a girl phase Period start date 7/12/15, boy phase started. Period start date 8/9/15, girl phase started. Conception plan sent Conceived FirstGender post-conception test 9/20/15 detected girl. Welcome Rose U/s scan 12/15/15 confirmed girl.
Contact info: Dr. Kuldeep Verma, email: drverma@urobiologics.com, Website: www.urobiologics.com, Ph. Cell: 1-313-574-7500 in USA, Toll free: 1-877 HE-OR-SHE

Kuldeep Verma
Urobiologics LLC
3135747500
email us here


Source: EIN Presswire

Waste-Derived Biogas Market 2018- Global Industry Analysis, By Key Players, Segmentation, Trends And Forecast By 2023

PUNE, MAHARASHTRA, INDIA, March 15, 2018 /EINPresswire.com/ — Waste-Derived Biogas Market 2018 

Wiseguyreports.Com Adds “Waste-Derived Biogas – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2023” To Its Research Database.

Description: 

The Waste-Derived Biogas market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023.Based on the Waste-Derived Biogas industrial chain, this report mainly elaborate the definition, types, applications and major players of Waste-Derived Biogas market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Waste-Derived Biogas market. 
The Waste-Derived Biogas market can be split based on product types, major applications, and important regions. 

Major Players in Waste-Derived Biogas market are: 
Bekon Biogas Energy Inc. 
ADI Systems Inc 
AAT GmbH & Co. 
Biotech Energy AG 
Clarke Energy 
Environmental Products & Technology Corp. 
Biogas Technology Ltd. 
Sarawak Energy 
Cargill Inc. 
Bedminster International 
Siemens 
Biogen Greenfinch 

Request for Sample Report@ https://www.wiseguyreports.com/sample-request/3050572-global-antimalarial-drug-market-size-status-and-forecast-2025

Major Regions play vital role in Waste-Derived Biogas market are: 
North America 
Europe 
China 
Japan 
Middle East & Africa 
India 
South America 
Others

Most important types of Waste-Derived Biogas products covered in this report are: 
Sewage 
Industrial Wastewater 
Agricultural Waste

Most widely used downstream fields of Waste-Derived Biogas market covered in this report are: 
Municipal Electricity Production 
On-site Electricity Production 
Transportation Fuel 
Other

Complete report details @ https://www.wiseguyreports.com/reports/3050572-global-antimalarial-drug-market-size-status-and-forecast-2025

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents:

Global Waste-Derived Biogas Industry Market Research Report 
1 Waste-Derived Biogas Introduction and Market Overview 
    1.1 Objectives of the Study 
    1.2 Definition of Waste-Derived Biogas 
    1.3 Waste-Derived Biogas Market Scope and Market Size Estimation 
      1.3.1 Market Concentration Ratio and Market Maturity Analysis 
      1.3.2 Global Waste-Derived Biogas Value ($) and Growth Rate from 2013-2023 
    1.4 Market Segmentation 
      1.4.1 Types of Waste-Derived Biogas 
      1.4.2 Applications of Waste-Derived Biogas 
      1.4.3 Research Regions 
          1.4.3.1 North America Waste-Derived Biogas Production Value ($) and Growth Rate (2013-2018) 
          1.4.3.2 Europe Waste-Derived Biogas Production Value ($) and Growth Rate (2013-2018) 
          1.4.3.3 China Waste-Derived Biogas Production Value ($) and Growth Rate (2013-2018) 
          1.4.3.4 Japan Waste-Derived Biogas Production Value ($) and Growth Rate (2013-2018) 
          1.4.3.5 Middle East & Africa Waste-Derived Biogas Production Value ($) and Growth Rate (2013-2018) 
          1.4.3.6 India Waste-Derived Biogas Production Value ($) and Growth Rate (2013-2018) 
          1.4.3.7 South America Waste-Derived Biogas Production Value ($) and Growth Rate (2013-2018) 
    1.5 Market Dynamics 
      1.5.1 Drivers 
          1.5.1.1 Emerging Countries of Waste-Derived Biogas 
          1.5.1.2 Growing Market of Waste-Derived Biogas 
      1.5.2 Limitations 
      1.5.3 Opportunities 
    1.6 Industry News and Policies by Regions 
      1.6.1 Industry News 
      1.6.2 Industry Policies

2 Industry Chain Analysis 
    2.1 Upstream Raw Material Suppliers of Waste-Derived Biogas Analysis 
    2.2 Major Players of Waste-Derived Biogas 
      2.2.1 Major Players Manufacturing Base and Market Share of Waste-Derived Biogas in 2017 
      2.2.2 Major Players Product Types in 2017 
    2.3 Waste-Derived Biogas Manufacturing Cost Structure Analysis 
      2.3.1 Production Process Analysis 
      2.3.2 Manufacturing Cost Structure of Waste-Derived Biogas 
      2.3.3 Raw Material Cost of Waste-Derived Biogas 
      2.3.4 Labor Cost of Waste-Derived Biogas 
    2.4 Market Channel Analysis of Waste-Derived Biogas 
    2.5 Major Downstream Buyers of Waste-Derived Biogas Analysis

……

8 Competitive Landscape 
    8.1 Competitive Profile 
    8.2 Bekon Biogas Energy Inc. 
      8.2.1 Company Profiles 
      8.2.2 Waste-Derived Biogas Product Introduction 
      8.2.3 Bekon Biogas Energy Inc. Production, Value ($), Price, Gross Margin 2013-2018E 
      8.2.4 Bekon Biogas Energy Inc. Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.3 ADI Systems Inc 
      8.3.1 Company Profiles 
      8.3.2 Waste-Derived Biogas Product Introduction 
      8.3.3 ADI Systems Inc Production, Value ($), Price, Gross Margin 2013-2018E 
      8.3.4 ADI Systems Inc Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.4 AAT GmbH & Co. 
      8.4.1 Company Profiles 
      8.4.2 Waste-Derived Biogas Product Introduction 
      8.4.3 AAT GmbH & Co. Production, Value ($), Price, Gross Margin 2013-2018E 
      8.4.4 AAT GmbH & Co. Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.5 Biotech Energy AG 
      8.5.1 Company Profiles 
      8.5.2 Waste-Derived Biogas Product Introduction 
      8.5.3 Biotech Energy AG Production, Value ($), Price, Gross Margin 2013-2018E 
      8.5.4 Biotech Energy AG Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.6 Clarke Energy 
      8.6.1 Company Profiles 
      8.6.2 Waste-Derived Biogas Product Introduction 
      8.6.3 Clarke Energy Production, Value ($), Price, Gross Margin 2013-2018E 
      8.6.4 Clarke Energy Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.7 Environmental Products & Technology Corp. 
      8.7.1 Company Profiles 
      8.7.2 Waste-Derived Biogas Product Introduction 
      8.7.3 Environmental Products & Technology Corp. Production, Value ($), Price, Gross Margin 2013-2018E 
      8.7.4 Environmental Products & Technology Corp. Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.8 Biogas Technology Ltd. 
      8.8.1 Company Profiles 
      8.8.2 Waste-Derived Biogas Product Introduction 
      8.8.3 Biogas Technology Ltd. Production, Value ($), Price, Gross Margin 2013-2018E 
      8.8.4 Biogas Technology Ltd. Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.9 Sarawak Energy 
      8.9.1 Company Profiles 
      8.9.2 Waste-Derived Biogas Product Introduction 
      8.9.3 Sarawak Energy Production, Value ($), Price, Gross Margin 2013-2018E 
      8.9.4 Sarawak Energy Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.10 Cargill Inc. 
      8.10.1 Company Profiles 
      8.10.2 Waste-Derived Biogas Product Introduction 
      8.10.3 Cargill Inc. Production, Value ($), Price, Gross Margin 2013-2018E 
      8.10.4 Cargill Inc. Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.11 Bedminster International 
      8.11.1 Company Profiles 
      8.11.2 Waste-Derived Biogas Product Introduction 
      8.11.3 Bedminster International Production, Value ($), Price, Gross Margin 2013-2018E 
      8.11.4 Bedminster International Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.12 Siemens 
      8.12.1 Company Profiles 
      8.12.2 Waste-Derived Biogas Product Introduction 
      8.12.3 Siemens Production, Value ($), Price, Gross Margin 2013-2018E 
      8.12.4 Siemens Market Share of Waste-Derived Biogas Segmented by Region in 2017 
    8.13 Biogen Greenfinch 
   
Continued…..

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Voice presentation Global Market 2018: Key Players Alibaba, Amazon, IBM, Microsoft

Voice presentation Market 2018 Global Industry Analysis, Opportunities and Forecast To 2022

PUNE , INDIA, March 15, 2018 /EINPresswire.com/ — Summary
Yesterday, our core interface with the digital world was a keyboard and mouse. Today it is a touchscreen. Tomorrow it will be voice commands. Just as iOS and Android run our lives now, so voice platforms will run our lives in the next decade.

Those companies who master voice – and related AI technologies such as machine learning, augmented reality and gesture control – could become some of the most valuable companies in the world.

In this report we look into trends, value chain, investment timeline and the major players in voice presentation.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3054241-voice-presentation-28-nov-2017-global-thematic-research

Companies mentioned
Alibaba
Alphabet
Amazon
AMD
Apple
ARM
Baidu
Facebook
HP Enterprise
IBM
iFlytek
Intel
LG Electronics
Medtronic
Microsoft
NEC
Nuance Communications
Nvidia
NXP
Oracle
Qualcomm
Samsung Electronics
SAP
Softbank
Sony
Splunk
STMicroelectronics
Tencent
Xilinx

Scope
– This report is part of our ecosystem of thematic investment research reports, supported by our “thematic engine”.
– About our Thematic Research Ecosystem
– Research has developed a unique thematic methodology for valuing technology, media and telecom companies based on their relative strength in the big investment themes that are impacting their industry. Whilst most investment research is underpinned by backwards looking company valuation models, thematic methodology identifies which companies are best placed to succeed in a future filled with multiple disruptive threats. To do this, tracks the performance of the top 600 technology, media and telecom stocks against the 50 most important themes driving their earnings, generating 30,000 thematic scores. The algorithms in “thematic engine” help to clearly identify the winners and losers within the TMT sector. Our 600 TMT stocks are categorised into 18 sectors. Each sector scorecard has a thematic screen, a risk screen and a valuation screen. Our thematic research ecosystem has a three-tiered reporting structure: single theme, multi-theme and sector scorecard. This report is a Single Theme report, offering in-depth research into a specific theme. It identifies winners and losers based on technology leadership, market position and other factors.

Reasons to buy
– Our thematic investment research product, supported by our thematic engine, is aimed at senior (C-Suite) executives in the corporate world as well as institutional investors.
– Corporations: Helps CEOs in all industries understand the disruptive threats to their competitive landscape
– Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TMT.
– Our unique differentiator, compared to all our rival thematic research houses, is that our thematic engine has a proven track record of predicting winners and losers.

Table of Content: Key Points
BIG TECH THEMES FOR
VOICE WILL BE THE NEXT COMPUTING PLATFORM
TECHNOLOGY BRIEFING
VOICE USE CASE : HOME DEVICES
VOICE USE CASE : ADVERTISING
TRENDS
VALUE CHAIN
VOICE IS CLOSELY LINKED TO THE MACHINE LEARNING VALUE CHAIN
VOICE IS ALSO LINKED TO THE VIRTUAL AND AUGMENTED REALITY VALUE CHAIN
INVESTMENT TIMELINE
VOICE BY THE NUMBERS
COMPANIES SECTION
INVESTMENT CONCLUSIONS
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3054241-voice-presentation-28-nov-2017-global-thematic-research

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire